2 курс / Гистология / Востриков_В_М_Олигодендроглия_в_мозге_человека_при_шизофрении

211

nucleus volume in schizophrenic patients previously treated with typical

antipsychotics. // Neuropsychopharmacology, 2001, 24: 47-54.

301.Schlosser R.G., Nenadic I., Wagner G., Gullmar D., von Consbruch K., Kohler S., Schultz C.C., Koch K., Fitzek C, Matthews P.M., Reichenbach J.R., Sauer H. White matter abnormalities and brain activation in schizophrenia: A combined DTI and fMRI study. // Schizophr. Res., 2007,89: 1-3, 1-11.

302.Schmitt A., Asan E., Lesch K.P., Kugler P. A splice variant of glutamate transporter GLT1/EAAT2 expressed in neurons: cloning and localization in rat nervous system. //Neuroscience, 2002, 109: 45-61.

303.Schmitt A., Wilczek K., Blennow K., Maras A., Jatzko A., Petroianu G., Braus D.F., Gattaz W.F. Altered thalamic membrane phospholipids in schizophrenia: a postmortem study. // Biol. Psychiatry, 2004, 56: 41-45.

304.Schultz S.K., O'Leary D.S., Boles Ponto L.L., Arndt S., Magnotta V., Watkins G.L., Hichwa R.D., Andreasen N.C. Age and regional cerebral blood flow in schizophrenia: age effects in anterior cingulate, frontal, and parietal cortex. // J. Neuropsychiatry Clin. Neurosci., 2002, 14: 19-24.

305.Schwyn R.C. An autoradiographic study of satellite cells in automic ganglia. //Am. J. Anat., 1967, 121: 727-740.

306.Selemon L.D., Goldman-Rakic P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. // Biol. Psychiatry, 1999,45: 17-25.

307.Selemon L.D., Lidow M.S., Goldman-Rakic P.S. Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. //Biol. Psychiatry, 1999, 46: 161-172.

308.Selemon L.D., Rajkowska G. Goldman-Rakich P.S. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. // Arch. Gen. Psychiatry, 1995,

52:805-818.

212

309. Selemon L.D, Mrzljak J, Kleinman J.E, Herman M.M, GoldmanRakic P.S. Regional specificity in the neuropathologic substrates of schizophrenia A morphometric analysis of Broca's area 44 and area 9. // Arch. Gen. Psychiatry, 2003, 60: 69-77.

310.Senitz D., Winkelmann E. Morphology of the orbitofrontal cortex in persons schizophrenic psychotics. A Golgi and electron microscopy study.

//Psychiatry, Neurology, Medical Psychology (Leipzig), 1981, 33: 1-9.

311.Shenton M.E., Dickey C.C, Framin M., McCarley R.W. A review of MRI findings in schizophrenia. // Schizophr. Res., 2001, 49: 1-52.

312.Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C, Nakazato M., Watanabe H., Shinoda N., Okada S., Iyo M. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. // Biol. Psychiatry, 2003, 54: 1, 70-75.

313.Shin Y.W., Kwon J.S., Ha Т.Н., Park H.J., Kim D.J., Hong S.B., Moon W.J., Lee J.M., Kim I.Y., Kim S.I., Chung E.C. Increased water diffusivity in the frontal and temporal cortices of schizophrenic patients. // Neuroimage, 2006, 30: 4, 1285-1291.

314.Shinar Y., McMorris F.A. Developing oligodendroglial express mRNA for insulin-like growth factor-1, a regulator of oligodendrocyte development. // J. Neurosci. Res., 1995, 42: 516-527.

315.Si X., Miguel-Hidalgo J.J., O'Dwyer G., Stockmeier G.A., Rajkowska G. Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression. // Neuropsychopharmacology, 2004, 29: 2088-2096.

316.Sigmundsson Т., Maier M., Toone B.K., Williams S.C., Simmons A., Greenwood K., Ron M.A. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study. // Schizophr. Res., 2003, 64: 1, 63-71.

213

317.Sirevaag A., Greenough W. Differential rearing effects on rat visual cortex synapses. III. Neuronal and glial nuclei, boutons, dendrites, and capillaries. //Brain Res., 1987, 424: 2, 320-332.

318.Sokolov B.P. Oligodendroglial abnonnalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies?. // Int. J. Neuropsychopharmacology, 2007, doi: 10.1017/S1461145706007322.

319.Sortwell C.E., Daley B.F., Pitzer M.R., McGuire S.O., Sladek J.R., Collier T.J. Oligodendrocyte-type 2 astrocyte-derived trophic factors increase survival of developing dopamine neurons through the inhibition of apoptotic cell death. // J. Сотр. Neurol., 2000, 426: 1, 143-153.

320.Stanley J.A„ Pettegrew J.W„ Keshavan M.S. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings - part I. //Biol. Psychiatry, 2000, 48: 357-368.

321.Stanley J.A., Vemulapalli M., Nutche J., Montrose D.M., Sweeney J.A., Pettegrew J.W., MacMaster F.P., Keshavan M.S. Redused N-acetyl- aspartate levels in schizophrenia patients with a younger onset age: A single-voxel 1H spectroscopy study. // Schizophr. Res., 2007, 93: 23-32.

322.Stark A.K., Uylings H.B., Sanz-Arigita E., Pakkenberg B. Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. // Am. J. Psychiatry., 2004, 161(5) 882-888.

323.Stevens J.R. Neuropathology of schizophrenia. // Arch. Gen. Psychiatry, 1982, 39: 1131-1139.

324.Strakowski S.M., Adler СМ., DeBello M.P. Volumetric MRI studies in mood disorders: Do they distinguish unipolar and bipolar disorder? // Bipolar Disord., 2002, 4: 80-88.

325.Strelau J., Unsicker K. GDNF family members and their receptors: expression and function in two oligodendroglial cell lines representing distinct stages of oligodendroglial development. // Glia, 1999, 26: 291-301.

214

326.Sugai Т., Kawamura M., Iritani S., Araki K., Makifuchi Т., Imai C, Nakamura R., Kakita A., Takahashi H., Nawa H. Prefrontal abnormality of schizophrenia revealed by DNA microarray impact on glial and neurotrophic gene expression. // Ann. NY Acad. Sci., 2005, 1025: 84-91.

327.Swaab D.F., Bao A.M., Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. // Ageing Res. Rev., 2005,4:2,141-194.

328.Szeligo F., Leblond C.P. Response of the three main types of glial cells of cortex and corpus callosum in rats handled during suckling or exposed to enriched, control and impoverished environments following weaning. // J. Сотр. Neurol., 1977, 172: 2, 247-263.

329.Szeszko P.R., Ardekani B.A., Ashtari M., Kumra S., Robinson D.G., Sevy S., Gunduz-Bruce H., Malhotra A.K., Kane J.M., Bilder R.M., Lim K.O. White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. // Am. J. Psychiatry, 2005, 162: 3, 602-605.

330.Tamminga C.A. Schizophrenia and glutamatergic transmission. // Crit. Rev. Neurobiol., 1998, 12: 21-36.

331.Tanaka K., Nogawa S., Ito D., Suzuki S., Dembo Т., Kosakai A., Fukuuchi Y. Activation of NG2-positive oligodendrocyte progenitor cells during post-ischemic reperfusion in the rat brain. // Neuroreport, 2001, 12: 10,2169-2174.

332.Taniike M., Mohri I., Eguchi N., Carsten Т., Beuckmann СТ., Suzuki K., Urade Y. Perineuronal oligodendrocytes protect against

neuronal apoptosis through the production of lipocalin-type prostaglandin D synthase in a genetic demyelinating model. // J. Neuroscience, 2002, 22: 4885-4896.

333. Tauscher-Wisniewski S., Tauscher J., Logan J., Christensen B.K., Mikulis D.J., Zipursky R.B. Caudate volume changes in first episode

215

psychosis parallel the effects of normal aging: 5-year follow-up study. //

Schizophr. Res., 2002, 58: 185-188.

334.Taylor S.5 Srinivasan В., Wordinger R.J., Roque R.S. Glutamate stimulates neurotrophin expression in cultured Muller cells. // Brain Res. Mol. Brain Res., 2003, 111: 1-2, 189-197.

335.Theodosis D.T., Bonhomme R., Vitiello S., Rougon G., Poulain D.A. Cell surface expression of polysialic acid on NCAM is a prerequisite for activity-dependent morphological neuronal and glial plasticity. // J. Neuroscience, 1999, 19: 10228-10236.

336.Thomas E.A., Dean В., Pavey G., Sutcliffe J.G. Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: Implications for the pathophysiology of psychiatric disorders. // PNAS, 2001,98:4066-4071.

337.Tkachev D, Mimmack M.L, Huffaker S.J, Ryan M, Bahn S. Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia. Int. J. Neoropsychopharmacology, 2007, doi: 10.1017/S1461145706007334.

338.Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman Т., Jones P.B., Starkey M., Webster M.J., Yolken R.H., Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. // Lancet, 2003, 362: 9386, 798-805.

339.Tosic M., Ott J., Barral S., Bovet P., Deppen P., Gheorghita F., Matthey M.L., Parnas J., Preisig M., Saraga M., Solida A., Timm S., Wang A.G., Werge Т., Cuenod M., Do K.Q. Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. // Am. J. Hum. Genet, 2006, 79: 586-592.

340.Toyooka K„ Asama K„ Watanabe Y„ Muratake T„ Takahashi M„ Someya T„ Nawa H. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. // Psychiatry Res., 2002, 110: 3, 249-257.

216

341.Tsai G.C., Coyle J.T. Glutamatergic mechanisms in schizophrenia. // Annu. Rev. Pharmacol. Toxicol., 2002, 42: 165-179.

342.Uranova N., Orlovskaya D., Vikhreva O., Zimina I., Kolomeets N., Vostrokov V., Rachmanova V. Electron microscopy of oligodendroglial in severe mental illness. // Brain Res. Bull., 2001, 55: 597-610.

343.Uranova N.A., Vostrikov V.M., Vichreva O.V., Zimina I.S., Kolomeets N.S., Orlovskaya D.D. The role of oligodendrocytes in the pathology in schizophrenia. // Int. J. Neuropsychopharmacology, 2007, 10: 4, 537-545.

344.Van Landeghem F.K., Weis Т., von Deimling A. Expression of PACAP and glutamate transporter proteins in satellite oligodendrocytes of human CNS. / Regul. Rept., 2007, 142: 52-59.

345.van Praag H., Kempermann G., Gage F.H. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. // Nature Neurosci., 1999, 2: 3, 266-270.

346.Vita A., Bressi S., Perani D., Invernizzi G., Giobbio G.M., Dieci M., Garbarini M., Del Sole A., Fazio F. High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients. //Am. J. Psychiatry, 1995, 152: 6, 876-882.

347.Vogt С and Vogt O. Importance of neuroanatomy in the field of neuropathology. //Neurology, 1951, 1: 3, 205-218.

348.Volz H.R., Riehemann S., Maurer I., Smesny S., Sommer M., Rzanny R., Holstein W., Czekalla J., Sauer H. Reduced phospho-diesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study. // Biol. Psychiatry, 2000,

47:11,954-961

349.Voruganti L., Awad A.G. Neuroleptic dysphoria: towards a new synthesis.//Psychopharmacology, 2004, 171: 121—132.

350.Webster M.J., Knable M.B., Johnston-Wilson N., Nagata K., Inagaki M., Yolken R.H. Immunohistochemical localization of phosphorylated glial

217

fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. // Brain, Behavior and Immunology, 2001, 215: 388-400.

351.Webster M.J., Knable M.B., O'Grady J., Orthmann J., Weickert C.S. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. // Mol. Psychiatry, 2002, 7: 9, 985-994.

352.Weickert C.S., Hyde T.M., Lipska B.K., Herman M.M., Weinberger D.R., Kleinman J.E. Reduced brain-derived neurotrophic factor in

prefrontal cortex of patients with schizophrenia. // Mol. Psychiatry, 2003,

8: 6, 592-610.

353.Weinberger D.R., Wagner R.L., Wyatt R.J. Neuropathological studies of schizophrenia: A selective review. // Schizophr. Bull., 1983, 9: 193-212.

354.Wennstrom M., Hellsten J., Tingstrom A. Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat amygdala. // Biol. Psychiatry, 2004, 55: 5, 464-471.

355.Wierzba-Bobrowicz Т., Lewandowska E., Kosno-Kruszewska E., Lechowicz W., Pasennik E., Schmidt-Sidor B. Degeneration of microglial cells in frontal and temporal lobes of chronic schizophrenics. // Folia

Neuropathol., 2004, 42: 3, 157-165.

356.Wierzba-Bobrowicz Т., Lewandowska E., Lechowicz W., Stepien Т., Pasennik E. Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics. //Folia Neuropathol., 2005, 43: 2, 81-89.

357.Wilkins A., Chandran S., Copston A. A role for oligodendrocytederived IGF-1 in trophic support of cortical neurons. // Glia, 2001, 36: 48-

358.Wilkins A, Majed H, Layfield R, Compston A, Chandran S. Oligodendrocytes promote neuronal survival and axonal length by distinct

218

intracellular mechanisms: A novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. // J. Neuroscience, 2003, 23: 49674974.

359.Winsberg M.E., Sachs N., Tate D.L., Adalsteinsson E., Spielman D., Ketter T.A. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. //Biol. Psychiatry, 2000, 47: 475-481.

360.Wolkin A., Jaeger J., Brodie J.D., Wolf A.P., Fowler J., Rotrosen J., Gomez-Mont F., Cancro R. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. //Am. J. Psychiatry, 1985, 142: 5, 564-571.

361.Wright I.C., Rabe-Hesketh S., Woodruff P.W., David A.S., Murray R.M., Bullmore E.T. Meta-analysis of regional braib volumes in schizophrenia. // Am. J. Psychiatry, 2000, 157: 16-25.

362.Wright JW, Kramar EA, Meighan SE, Harding JW. Extracellular matrix molecules, long-term potentiation, memory consolidation and the brain angiotensin system. //Peptides, 2002, 23: 1, 221-246.

363.Xing G.Q., Russell S., Webster M.J., Post R.M. Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder. // Int. J. Neuropsychopharmacol., 2004, 7: 143-153.

364.Yakovlev P.L., Lecours A.R. The myelogenetic cycles of regional brain maturation of the brain. / In: Minkowski A. (Ed) Regional Development of the Brain in Early Life, Blackwell, Oxford, 1967, pp. 3-70.

365.Yanik M., Kocyigit A., Tutkun H., Vural H., Herken H. Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia. // Biol. Trace Elem. Res., 2004, 98: 2, 109-117.

366.Yao J.K., Leonard S., Reddy R. Altered glutathione redox state in schizophrenia. //Dis. Markers, 2006, 22: 83-93.

367.Yao J.K., Leonard S., Reddy R.D. Increased nitric oxide radicals in postmortem brain from patients with schizophrenia. // Schizophr. Bull., 2004, 30: 923-934.

368.Yurov Y.B., Iourov I.Y., Vorsanova S.G., Demidova LA., Kravetz V.S., Beresheva A.K., Kolotii A.D., Monakchov V.V., Uranova N.A., Vostrikov V.M., Soloviev I.V., Liehr T. The schizophrenia brain exhibita low-level aneuploidy involving chromosome 1. Schizophrenia Research, 2008,98: 139-147.

369.Zhang L.X., Levine S., Dent G., Zhan Y., Xing G., Okimoto D., Kathleen Gordon M., Post R.M., Smith M.A. Maternal deprivation increases cell death in the infant rat brain. // Brain Res. Dev. Brain Res., 2002,133: 1,1-11.

370.Zhvaniia M.G. Influence of social isolation on the ultrastructure off glial cells of dog's forebrain. // Glia, 2002, Supp. 1, S 26, P 66.

371.Ziegeler A., Bernstein H.G., Krell D., Baumann В., Danos P., Diekmann S., Bogerts B. Is there more activated microglia in the dorsolateral prefrontal cortex (DLPFC) in schizophrenia? (Abstracts of the "Xl-th Biennial Winter Workshop on Schizophrenia", Davos, Switzerland, February 24-March 1, 2002). // Schizophr. Res., 2002, 53: 3, 108.